CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 279 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $72,674,000 | -74.7% | 722,031 | -83.3% | 0.02% | -75.6% |
Q3 2014 | $287,097,000 | -44.7% | 4,327,653 | -41.8% | 0.08% | +11.4% |
Q2 2014 | $518,964,000 | +128.6% | 7,432,872 | +139.5% | 0.07% | +12.9% |
Q1 2014 | $226,993,000 | +11.4% | 3,103,121 | +4.9% | 0.06% | +8.8% |
Q4 2013 | $203,805,000 | -53.9% | 2,959,257 | -57.5% | 0.06% | -13.6% |
Q3 2013 | $441,988,000 | +171.1% | 6,954,998 | +106.0% | 0.07% | +29.4% |
Q2 2013 | $163,013,000 | – | 3,375,690 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |